DiBiase Mary
- SEC CIK
- 0001880179
No open-market purchases or sales filed in the past year.
Current role at each company
- XFOR X4 Pharmaceuticals, IncChief Operating Officeras of Feb 14, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists DiBiase Mary as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 (view filing)6:15 PM ET | Jan 24 | 3 days | DiBiase MaryChief Operating Officer | SSale | −22.3K | $0.4535 | −$10.1K | −4.3%491.0K after | |
| Oct 8, 2024 (view filing) | Oct 7 | 1 day | DiBiase MaryChief Operating Officer | SSale | −67.7K | $0.57 | −$38.6K | −13.0%452.1K after | |
| Sep 11, 2024 (view filing) | Sep 9 | 2 days | DiBiase MaryChief Operating Officer | SSale | −2.64K | $0.66 | −$1.74K | −0.9%289.1K after | |
| Mar 11, 2024 (view filing) | Mar 11 | Same day | DiBiase MaryChief Operating Officer | SSale | −15.4K | $0.88 | −$13.6K | −5.0%291.8K after | |
| Feb 12, 2024 (view filing) | Feb 12 | Same day | DiBiase MaryChief Operating Officer | SSale | −3.68K | $1.01 | −$3.72K | −1.2%307.2K after | |
| Nov 3, 2023 (view filing) | Nov 1 | 2 days | DiBiase MaryChief Operating Officer | SSale | −67.7K | $0.73 | −$49.4K | −17.9%310.8K after | 10b5-1 |
| Sep 12, 2023 (view filing) | Sep 8 | 4 days | DiBiase MaryChief Operating Officer | SSale | −2.64K | $1.25 | −$3.30K | −1.8%147.9K after | |
| Jul 5, 2023 (view filing) | Jun 30 | 5 days | DiBiase MaryChief Operating Officer | SSale | −464 | $1.89 | −$876.96 | −0.3%150.5K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | DiBiase MaryChief Operating Officer | SSale | −857 | $1.93 | −$1.65K | −0.6%151.0K after | |
| Jun 16, 2023 (view filing) | Jun 15 | 1 day | DiBiase MaryChief Operating Officer | SSale | −857 | $2.23 | −$1.91K | −0.6%151.9K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | DiBiase MaryChief Operating Officer | SSale | −18.2K | $0.84 | −$15.3K | −10.6%152.7K after | |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | DiBiase MaryChief Operating Officer | SSale | −4.35K | $0.93 | −$4.04K | −2.5%170.9K after | |
| Aug 19, 2022 (view filing) | Aug 17 | 2 days | DiBiase MaryChief Operating Officer | SSale | −1.71K | – | – | −1.0%177.9K after | |
| Jul 1, 2022 (view filing) | Jun 30 | 1 day | DiBiase MaryChief Operating Officer | SSale | −1.58K | – | – | −0.9%179.6K after | |
| Jun 27, 2022 (view filing) | Jun 24 | 3 days | DiBiase MaryChief Operating Officer | SSale | −856 | – | – | −0.5%181.2K after | |
| Jun 17, 2022 (view filing) | Jun 16 | 1 day | DiBiase MaryChief Operating Officer | SSale | −856 | – | – | −0.5%182.0K after | |
| Feb 14, 2022 (view filing) | Feb 11 | 3 days | DiBiase MaryChief Operating Officer | SSale | −12.5K | – | – | −13.9%77.9K after |